We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Raloxifene as an Adjuvant Treatment of the Negative Symptoms of Schizophrenia in Post-menopausal Women

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01573637
Recruitment Status : Completed
First Posted : April 9, 2012
Last Update Posted : August 24, 2015
Hospital Sant Joan de Deu
Parc Sanitari Sant Joan de Déu
Stanley Medical Research Institute
Information provided by (Responsible Party):
Fundació Sant Joan de Déu